Patient-specific dosimetry for intracavitary 32P-chromic phosphate colloid therapy of cystic brain tumours

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 40, Issue 10, 2013, Pages 1532-1541

  Denis Bacelar, Ana M ^a   Romanchikova, Marina ^a   Chittenden, Sarah ^b   Saran, Frank H ^b   Mandeville, Henry ^b   Du, Yong ^b   Flux, Glenn D ^b  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

Astrocytoma; Craniopharyngioma; Intracavitary radiocolloids; Monte Carlo simulations; SPECT CT MR; Voxel dosimetry

Indexed keywords

CHROMIUM PHOSPHATE P 32; PHOSPHATE P 32; RADIOISOTOPE; TECHNETIUM 99M; TIN TC 99M; TRACER; UNCLASSIFIED DRUG;

ARTICLE; ASTROCYTOMA; BRAIN CYST; BRAIN TUMOR; CASE REPORT; CHILD; CRANIOPHARYNGIOMA; DOSIMETRY; DRUG ABSORPTION; DRUG DISTRIBUTION; DRUG HALF LIFE; DRUG UPTAKE; FEMALE; HISTOGRAM; HUMAN; INFORMATION PROCESSING; IRRADIATION; MALE; RADIATION; SCHOOL CHILD; SIMULATION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TREATMENT PLANNING; TREATMENT RESPONSE;

ASTROCYTOMA; BRAIN NEOPLASMS; CHILD; CHROMIUM COMPOUNDS; COLLOIDS; CRANIOPHARYNGIOMA; CYSTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MODELS, BIOLOGICAL; PHOSPHATES; PITUITARY NEOPLASMS; RADIOMETRY; RADIOPHARMACEUTICALS; TECHNETIUM COMPOUNDS; TIN COMPOUNDS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 84885485854     PISSN: 16197070     EISSN: 16197089     Source Type: Journal    
DOI: 10.1007/s00259-013-2451-6     Document Type: Article

References (30)

1. Karavitaki N, Cudlip S, Adams CB, Wass JA. Craniopharyngiomas. Endocr Rev. 2006;27(4):371-97. doi: 10.1210/er.2006-0002.
2. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007;114(2):97-109. doi: 10.1007/s00401-007-0243-4.
3. Tihan T, Fisher PG, Kepner JL, Godfraind C, McComb RD, Goldthwaite PT, et al. Pediatric astrocytomas with monomorphous pilomyxoid features and a less favorable outcome. J Neuropathol Exp Neurol. 1999;58(10):1061-8.
4. Habrand JL, Ganry O, Couanet D, Rouxel V, Levy-Piedbois C, Pierre-Kahn A, et al. The role of radiation therapy in the management of craniopharyngioma: a 25-year experience and review of the literature. Int J Radiat Oncol Biol Phys. 1999;44(2):255-63.
5. Leksell L. The stereotaxic method and radiosurgery of the brain. Acta Chir Scand. 1951;102(4):316-9.
6. Leksell L, Liden K. A therapeutic trial with radioactive isotopes in cystic brain tumours. radioisotope techniques Vol 1, Med Physiol Appl, HM Stationery Office, Oxford. 1952;1-4.
7. Barriger RB, Chang A, Lo SS, Timmerman RD, DesRosiers C, Boaz JC, et al. Phosphorus-32 therapy for cystic craniopharyngiomas. Radiother Oncol. 2011;98(2):207-12. doi: 10.1016/j.radonc.2010.12.001.
8. Shahzadi S, Sharifi G, Andalibi R, Zali A, Ali-Asgari A. Management of cystic craniopharyngiomas with intracavitary irradiation with 32P. Arch Iran Med. 2008;11(1):30-4.
9. Zhao R, Deng J, Liang X, Zeng J, Chen X, Wang J. Treatment of cystic craniopharyngioma with phosphorus-32 intracavitary irradiation. Childs Nerv Syst. 2010;26(5):669-74. doi: 10.1007/s00381-009-1025-1.
10. Derrey S, Blond S, Reyns N, Touzet G, Carpentier P, Gauthier H, et al. Management of cystic craniopharyngiomas with stereotactic endocavitary irradiation using colloidal 186Re: a retrospective study of 48 consecutive patients. Neurosurgery. 2008;63(6):1045-52. doi: 10.1227/01.NEU.0000335786. 10968.2F. discussion 52-3.
11. Hasegawa T, Kondziolka D, Hadjipanayis CG, Lunsford LD. Management of cystic craniopharyngiomas with phosphorus-32 intracavitary irradiation. Neurosurgery. 2004;54(4):813-20. discussion 20-2.
12. Voges J, Sturm V, Lehrke R, Treuer H, Gauss C, Berthold F. Cystic craniopharyngioma: long-term results after intracavitary irradiation with stereotactically applied colloidal beta-emitting radioactive sources. Neurosurgery. 1997;40(2):263-9. discussion 9-70.
13. Pollock BE, Lunsford LD, Kondziolka D, Levine G, Flickinger JC. Phosphorus-32 intracavitary irradiation of cystic craniopharyngiomas: current technique and long-term results. Int J Radiat Oncol Biol Phys. 1995;33(2):437-46.
14. Fig LM, Shapiro B, Taren J. Distribution of [32P]-chromic phosphate colloid in cystic brain tumors. Stereotact Funct Neurosurg. 1992;59(1-4):166-8.
15. Kumar PP, Good RR, Skultety FM, Jones EO, Chu WK. Retreatment of recurrent cystic craniopharyngioma with chromic phosphorus P 32. J Natl Med Assoc. 1986;78(6):542-3, 547-9.
16. Taasan V, Shapiro B, Taren JA, Beierwaltes WH, McKeever P, Wahl RL, et al. Phosphorus-32 therapy of cystic grade IV astrocytomas: technique and preliminary application. J Nucl Med. 1985;26(11):1335-8.
17. Lunsford LD, Gumerman L, Levine G. Stereotactic intracavitary irradiation of cystic neoplasms of the brain. Appl Neurophysiol. 1985;48(1-6):146-50.
18. Kobayashi T, Kageyama N, Ohara K. Internal irradiation for cystic craniopharyngioma. J Neurosurg. 1981;55(6):896-903. doi: 10.3171/jns.1981.55.6. 0896.
19. Shapiro B, Fig LM, Gross MD. Intracavitary therapy of craniopharyngiomas. Q J Nucl Med. 1999;43(4):367-74.
20. Janicki C, Seuntjens J. Re-evaluation of the dose to the cyst wall in P-32 radiocolloid treatments of cystic brain tumors using the dose-point-kernel and Monte Carlo methods. Med Phys. 2003;30(9):2475-81.
21. Loevinger R. The dosimetry of beta sources in tissue; the point-source function. Radiology. 1956;66(1):55-62.
22. Gutin PH, Klemme WM, Lagger RL, MacKay AR, Pitts LH, Hosobuchi Y. Management of the unresectable cystic craniopharyngioma by aspiration through an Ommaya reservoir drainage system. J Neurosurg. 1980;52(1):36-40. doi: 10.3171/jns.1980.52.1.0036.
23. Heard S, Flux GD, Guy MJ, Ott RJ. Monte Carlo simulation of 90Y Bremsstrahlung imaging. Nuclear Science Symposium Conference Record, 2004 IEEE. vol 6. 2004. p. 3579-3583. doi: 10.1109/NSSMIC.2004.1466658
24. Kawrakow I. Accurate condensed history Monte Carlo simulation of electron transport. I. EGSnrc, the new EGS4 version. Med Phys. 2000;27(3):485-98.
25. Stabin MG, da Luz LC. Decay data for internal and external dose assessment. Health Phys. 2002;83(4):471-5.
26. Eckerman KF, Endo A. MIRD: radionuclide data and decay Schemes. Reston: Society of Nuclear Medicine; 2007.
27. Lanconelli N, Pacilio M, Lo Meo S, Botta F, Di Dia A, Aroche AT, et al. A free database of radionuclide voxel S values for the dosimetry of nonuniform activity distributions. Phys Med Biol. 2012;57(2):517-33. doi: 10.1088/0031-9155/57/2/517.
28. Bolch WE, Bouchet LG, Robertson JS, Wessels BW, Siegel JA, Howell RW, et al. MIRD pamphlet No. 17: the dosimetry of nonuniform activity distributions - radionuclide S values at the voxel level. Medical Internal Radiation Dose Committee. J Nucl Med. 1999;40(1):11S-36S.
29. Rojas EL, Al-Dweri FM, Lallena AM, Bodineau C, Galan P. Dosimetry for radiocolloid therapy of cystic craniopharyngiomas. Med Phys. 2003;30(9):2482-92.
30. Hafeli UO, Pauer GJ, Unnithan J, Prayson RA. Fibrin glue system for adjuvant brachytherapy of brain tumors with 188Re and 186Re-labeled microspheres. Eur J Pharm Biopharm. 2007;65(3):282-8. doi: 10.1016/j.ejpb.2006. 10.016.